This project is led by Julie Di Cristofaro (PhD, HDR, CR EFS), Christophe Picard, (MD, PhD, HDR, EFS) and Pascal Pedini (PharmD, PhD, EFS), it benefits from many collaborations, including that with the team of Pr Pascal Chanez (APHM, INSERM, C2VN).
Projects
Based on the data from the previous project, the main objective of this project is to define the biomarkers particularly involved in the phenomena of tolerance, inflammation and rejection in order to improve the diagnostic and therapeutic management of transfused, grafted or transplanted patients as well as their donor selection.
The immunological safety of transfusions is based, among other things, on the compatibility of erythrocyte blood groups. Today there are about 380 different antigens in 44 systems. More than half of them are considered rare, i.e. their frequency in the general population is less than 4/1000.